Professor Ian Frazer

Emeritus Professor

Faculty of Medicine


Professor Ian Frazer is a clinician scientist, trained as a clinical immunologist in Scotland. As a professor at the University of Queensland, he leads a research group working at TRI in Brisbane, Australia on the immunobiology of epithelial cancers. He is recognised as co-inventor of the technology enabling the HPV vaccines, currently used worldwide to help prevent cervical cancer. He heads a biotechnology company, Jingang Medicine (Aus) Pty Ltd, working on new vaccine technologies, and is a board member of several companies and not for profit organisations. He was the inaugural president of the Australian Academy of Health and Medical Sciences, and a member of the Australian National Science and Technology Council. He chairs the Australian Medical Research Advisory Board of the Medical Research Future Fund.

He was recognised as Australian of the Year in 2006. He was recipient of the Prime Ministers Prize for Science, and of the Balzan Prize, in 2008, and was elected Fellow of the Royal Society of London in 2012. He was appointed Companion of the Order of Australia in the Queen’s Birthday Honours list in 2013.


  • Royal College of Physicians of Edinburgh, Royal College of Physicians of Edinburgh
  • Royal College of Pathologists of Australasia, Royal College of Pathologists of Australasia
  • Bachelor (Honours) of Science (Advanced), University of Edinburgh
  • Doctoral Diploma of Medicine, University of Melbourne
  • Bachelor of Medicine Surgery, University of Edinburgh
  • Bachelor (Honours) of Science (Advanced), University of Edinburgh


View all Publications


View all Supervision



Book Chapter

  • Frazer, Ian H. (2010). Human papillomaviruses. Vaccines: a biography. (pp. 361-373) edited by Andrew W. Artenstein. New York, United States: Springer. doi: 10.1007/978-1-4419-1108-7_21

  • Jansen, Kathrin U. and Frazer, Ian H. (2010). Vaccines against human papillomaviruses. New generation vaccines. (pp. 954-961) edited by Myron M. Levine. New York, U.S.A.: Informa Healthcare.

  • Frazer, Ian H. (2009). Antigen recognition and self–non-self discrimination. Autoimmune neurological disease. (pp. 1-13) edited by Michael P. Pender and Pamela A. McCombe. Cambridge, United Kingdom: Cambridge University Press. doi: 10.1017/cbo9780511526916.002

  • Frazer, Ian H. (2009). Vaccines against human papillomavirus infection. Vaccines against human papillomavirus infection. (pp. 977-986) edited by Levine, M. M. United States: Informa Healthcare.

  • Frazer, I.H. and Appleton. S. (2007). Vaccines to prevent and treat human papillomavirus associated anogenital disease. The Cervix. (pp. 609-621) edited by Jordan, J., Singer, A. and et al.. United States: Blackwell publishing. doi: 10.1002/9781444312744.ch44

  • Edwards, S. J., Basser, R. L. and Frazer, I. H. (2005). Development of a Vaccine Against Human Papillomavirus (HPV. Vaccines: Frontiers in Design and Development. (pp. 210-230) edited by Philippe Moingeon Stallergenes. United Kingdom: Horizon Bioscience.

  • Frazer, I. H. (2004). Human Papillomavirus. Vaccines: Preventing Disease & Protecting Health. (pp. 140-143) edited by Ciro A. de Quadros. Washington, D.C.: Pan American Health Organisation.

  • Boslego, J., Liu, X. and Frazer, I. H. (2004). Vaccines Against Human Papillomavirus Infection. New Generation Vaccines. (pp. 977-986) edited by Myron M. Levine, James B. Kaper, Rino Rappuoli, Margaret A. Liu and Michael F. Good. New York: Marcel Dekker, Inc..

  • Frazer, I. H. (2001). Wart and hepatitis vaccines. Reproductive medicine in the twenty first century. (pp. 173-181) edited by D. L. Healy, R. McLachlan, G. T. Kovacs and O. Rodriguex-Armas. UK: The Parthenon Publishing Group Ltd.

  • Frazer, I. H. and Tindle, R. (1999). Cell mediated immunity to papillomaviruses. Current research on papillomaviruses. (pp. 151-164) edited by Charles Lacey. Leeds, England: Leeds University Press.

  • Leggatt, G. R. and Frazer, I. H. (1999). Immunology of HPV infection. Vaccines for Human Papillomavirus Infection and Anogenital Disease. (pp. 13-31) edited by Robert W. Tindle. Austin, USA: R. G. Landes Company.

  • Frazer, I. H. and Dunn, L. A. (1999). Papillomavirus. Persistent Viral Infections. (pp. 131-146) edited by Rafi Ahmed and Irvin S.Y. Chen. Chichester, USA: John Wiley & Sons.

  • Frazer, I. H., Tindle, R. W., Fernando, G. J., Malcolm, K. M., Herd, K. A., McFadyen, S. M., Cooper, P. D. and Ward, B. G. (1999). Safety and Immunogenicity of HPV16 E7/Algammulin. Vaccines for Human Papillomavirus Infection and Anogenital Disease. (pp. 91-104) edited by R. W. Tindle. Austin, USA: R.G. Landes Company.

  • Zhou, J. and Frazer, I. H. (1996). Papovaviridiae: capsid structure and capsid protein function. Papillomavirus reviews: current research on papillomaviruses. (pp. 93-100) edited by Charles Lacey. Leeds, Yorkshire, United Kingdom: Leeds University Press.

Journal Article

Conference Publication

Edited Outputs

Other Outputs

Grants (Administered at UQ)

PhD and MPhil Supervision

Current Supervision

Completed Supervision